Alps Alpine Co., Ltd. (APELY)

Sage Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	116,056	147,941	122,667	84,173	139,730	153,067
Cash & Short-Term Investments	116,056	147,941	122,667	84,173	139,730	153,067
Cash Growth	-5.06%	20.60%	45.73%	-39.76%	-8.71%	18.11%
Receivables	162,289	164,915	158,292	176,711	156,289	147,963
Inventory	143,385	138,634	163,715	165,424	133,400	95,777
Other Current Assets	36,922	43,456	46,784	40,207	29,630	28,492
Total Current Assets	458,652	494,946	491,458	466,515	459,049	425,299
Property, Plant & Equipment	139,532	136,673	134,211	158,545	191,260	181,270
Long-Term Investments	57,466	71,830	84,790	78,411	58,611	52,593
Goodwill	-	-	57	285	516	752
Other Intangible Assets	23,069	22,031	26,494	26,199	27,715	27,431
Long-Term Deferred Tax Assets	15,055	15,234	16,978	7,040	6,367	6,938
Other Long-Term Assets	11,311	1	1	2	2	2
Total Assets	705,085	740,715	753,989	736,997	743,520	694,285
Accounts Payable	99,705	90,381	93,964	98,547	85,243	79,932
Accrued Expenses	21,218	24,233	27,338	25,160	28,242	34,020
Short-Term Debt	16,764	44,288	50,463	77,209	57,037	50,868
Current Income Taxes Payable	6,506	7,350	8,671	6,487	6,705	3,345
Other Current Liabilities	61,441	60,609	67,275	57,167	57,052	56,273
Total Current Liabilities	205,634	226,861	247,711	264,570	234,279	224,438
Long-Term Debt	56,490	56,499	78,838	44,728	56,234	67,068
Long-Term Deferred Tax Liabilities	23,851	23,717	17,592	8,140	4,136	3,730
Other Long-Term Liabilities	4,304	4,865	3,094	2,883	8,833	7,157
Total Liabilities	303,328	325,202	361,167	337,217	318,214	315,908
Common Stock	38,730	38,730	38,730	38,730	38,730	38,730
Additional Paid-In Capital	123,873	123,872	124,138	124,206	124,549	124,592
Retained Earnings	204,950	213,942	184,350	222,385	217,097	198,501
Treasury Stock	-30,296	-28,254	-28,365	-28,581	-26,219	-26,396
Comprehensive Income & Other	63,067	65,708	72,321	41,475	35,448	9,706
Total Common Equity	400,324	413,998	391,174	398,215	389,605	345,133
Minority Interest	1,433	1,515	1,648	1,565	35,701	33,244
Shareholders' Equity	401,757	415,513	392,822	399,780	425,306	378,377
Total Liabilities & Equity	705,085	740,715	753,989	736,997	743,520	694,285
Total Debt	73,254	100,787	129,301	121,937	113,271	117,936
Net Cash (Debt)	42,802	47,154	-6,634	-37,764	26,459	35,131
Net Cash Growth	-	-	-	-	-24.69%	18.18%
Net Cash Per Share	208.25	229.30	-32.27	-183.57	127.67	171.43
Filing Date Shares Outstanding	204.2	205.55	205.58	205.48	206.15	207.12
Total Common Shares Outstanding	204.2	205.65	205.58	205.48	207.21	207.12
Working Capital	253,018	268,085	243,747	201,945	224,770	200,861
Book Value Per Share	1960.42	2013.09	1902.76	1937.98	1880.28	1666.31
Tangible Book Value	377,255	391,967	364,623	371,731	361,374	316,950
Tangible Book Value Per Share	1847.45	1905.97	1773.61	1809.09	1744.04	1530.24
Order Backlog	-	52,886	53,158	63,109	84,769	76,856

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.